PMID- 33226866
OWN - NLM
STAT- MEDLINE
DCOM- 20220907
LR  - 20220907
IS  - 1724-6067 (Electronic)
IS  - 1120-7000 (Linking)
VI  - 32
IP  - 5
DP  - 2022 Sep
TI  - Does obesity lead to lower rates of clinically meaningful improvement or 
      satisfaction after total hip arthroplasty? A propensity score-matched study.
PG  - 610-619
LID - 10.1177/1120700020974656 [doi]
AB  - BACKGROUND: Current literature lacks consensus regarding the impact of obesity on 
      clinical outcomes of total hip arthroplasty (THA). The variability of results may 
      reflect the lack of minimal clinically important difference (MCID) analysis, 
      which helps to standardise the interpretation of patient-reported outcome 
      measures (PROMs). We compared the PROMs, patient satisfaction and survivorship 
      between obese and non-obese patients after THA. METHODS: Prospectively collected 
      registry data of 192 obese patients and 192 propensity score-matched controls who 
      underwent primary THA at a single institution were reviewed. Clinical outcomes 
      and satisfaction rates were assessed at 6 months and 2 years. Reoperations for 
      surgical complications and revision rates were analysed. RESULTS: Obese patients 
      had a significantly poorer Oxford Hip Score (OHS) at 6 months and WOMAC-Function 
      at 2 years. However, there was no difference in overall WOMAC, WOMAC-Pain, 
      WOMAC-stiffness, SF-36 mental and physical component summary (PCS). A similar 
      proportion of patients in each group achieved the MCID for OHS, WOMAC and SF-36 
      PCS. At 2 years, 90.3% of obese patients and 91.7% of controls were satisfied 
      (p = 0.755). At a mean follow-up of 9 years, there were 5 reoperations (2.6%) for 
      surgical complications in the obese group and 1 (0.5%) in the control group; 
      whereas 12 revisions (6.3%) were recorded in the obese group and 3 (1.6%) in the 
      control group (p = 0.021). CONCLUSIONS: Despite a higher revision rate, obese 
      patients undergoing THA may experience a similar level of clinical meaningful 
      improvement and satisfaction as their non-obese counterparts. This study provides 
      valuable prognostic information for obese patients and guides preoperative 
      counselling.
FAU - Goh, Graham S
AU  - Goh GS
AD  - Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.
FAU - Zeng, Gerald J
AU  - Zeng GJ
AD  - Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.
FAU - Tay, Darren K-J
AU  - Tay DK
AD  - Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.
FAU - Lo, Ngai-Nung
AU  - Lo NN
AD  - Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.
FAU - Yeo, Seng-Jin
AU  - Yeo SJ
AD  - Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.
FAU - Liow, Ming Han Lincoln
AU  - Liow MHL
AD  - Department of Orthopaedic Surgery, Singapore General Hospital, Singapore.
LA  - eng
PT  - Journal Article
DEP - 20201123
PL  - United States
TA  - Hip Int
JT  - Hip international : the journal of clinical and experimental research on hip 
      pathology and therapy
JID - 9200413
SB  - IM
MH  - *Arthroplasty, Replacement, Hip/adverse effects
MH  - Humans
MH  - Obesity/complications/surgery
MH  - Personal Satisfaction
MH  - Propensity Score
MH  - Retrospective Studies
MH  - Treatment Outcome
OTO - NOTNLM
OT  - Body mass index
OT  - hip arthroplasty
OT  - obese
OT  - outcomes
OT  - quality of life
OT  - survivorship
EDAT- 2020/11/24 06:00
MHDA- 2022/09/08 06:00
CRDT- 2020/11/23 17:09
PHST- 2020/11/24 06:00 [pubmed]
PHST- 2022/09/08 06:00 [medline]
PHST- 2020/11/23 17:09 [entrez]
AID - 10.1177/1120700020974656 [doi]
PST - ppublish
SO  - Hip Int. 2022 Sep;32(5):610-619. doi: 10.1177/1120700020974656. Epub 2020 Nov 23.